MDT's Ishrak: U.S. Should "Absolutely" Adopt EU Regulatory System (written by Lauren Uzdienski @ HealthPointCapital)
In comments to the Financial Times, Medtronic CEO Omar Ishrak criticized the FDA for a slow regulatory process that limits patient access to care. In the EU, "the response time is quicker, the clinical trial cycle is quicker, and maybe some of the barriers are less stringent," Mr Ishrak told the FT. He also spoke in favor of adopting a regulatory process more like the Europe's, adding, "It will certainly put products on the market more quickly, so from a very selfish dev...
The Orthopedics Industry 